Conflict of Interest Curriculum Eric Jackson, PharmD University of Connecticut School of Medicine Department of Family Medicine.

Slides:



Advertisements
Similar presentations
VCOM Conflict of Interest Policy Overview of Financial Conflict of Interest Related to Research December 4, 2013.
Advertisements

CME 101 The Application Process Sponsored by the Office of Continuing Medical Education.
Physician Relationships with The Pharmaceutical Industry Steven R. Craig, MD, FACP June 22, 2010.
Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
Introduction to Drug Information Services Ch.#1. An introductory course to teach the students basic principles of DI retrieval. Designed to help students.
Conflict of Interest (COI) Objectives: Provide an overview of financial conflict of interest (FCOI) related to research activities at Gillette Describe.
Conflict of Interest in Physician-Industry Relationships
National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships Rev. 10/21/2014 APGO Interaction with Industry: A Medical.
Personal financial benefit or economic interest from one’s position that may inappropriately: influence the employee’s judgment compromise the employee’s.
April 2012 Policy & Advocacy Briefing Analysis of CMS Consultant Pharmacist Independence Proposal ASCP’s Policy & Advocacy Department
Development and Implementation of a Theme Based Introductory Pharmacy Practice Experience (IPPE) Program S. Scott Wisneski, Pharm.D., MBA, Louis D. Barone,
International Federation of Accountants International Education Standards for Professional Accountants Mark Allison, Executive Director Institute of Chartered.
Pharmaceutical Sciences NON MEDICAL PRESCRIBING Non Medical Prescribing Alison Hogg.
Marketing to Doctors – Payments for Loyalty Julie Brill Assistant Attorney General Vermont Attorney General ’ s Office Montpelier,
1 Physician-Industry Transparency: The U.S. Physician Payment Sunshine Act.
1 UCDHS Vendor Relations Policy Development & Implementation Teresa Porter, CHC - Chief Compliance Officer David Levine, JD - Legal Counsel Allan Siefkin,
Conflict of Interest. Definition  “A conflict of interest is a situation in which financial or other personal considerations have the potential to compromise.
Dr. Dalal AL-Matrouk KBA Farwaniya Hospital
ISA 220 – Quality Control for Audits of Historical Financial Information
Promoting Objectivity in Research by Managing, Reducing, or Eliminating Conflicts of Interest UT HOP UT HOP The University of Texas at Austin.
Family Medicine Program By the end of this session, faculty will 1.Understand what is meant by competence and the competence trajectory expected during.
The Prescription Project: Ending Conflicts of Interest; Promoting Evidence-Based Prescribing Marcia Hams, Director of Prescription Policy Initiatives The.
Rice’s New Staff Conflict of Interest Policy and Procedures Administrators’ Forum Richard A. Zansitis General Counsel April 2008.
THE ORTHOPAEDIC SURGEON’S RELATIONSHIPS WITH INDUSTRY AAOS ETHICS COMMITTEE Kenneth C. Thomas, MD 1.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
Role of Industry in Clinical Care, Research and Education Rev 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
VCU School of Medicine Policy on Industry Relations Effective July 1, 2009.
1 Welcome Working with Volunteers Course Heelis, 10 th January 2012 Mike Elliott, National Volunteering Manager Michelle Upton, Working Holidays Officer.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
Teaching RCR to undergraduate and graduate audiences: college sophomores, seniors and graduate students Julio F. Turrens, Ph.D. Associate Dean College.
New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.
Being a Successful Graduate Student  As a new graduate student, you are likely wondering:  What is graduate school like?  What should I expect?  Can.
Will Disclosure Quiet the Industry’s Critics? Peter Lurie, MD, MPH Deputy Director Health Research Group at Public Citizen Presented before The National.
“Delivering Therapeutic Agents” - Marketing and Communication Strategies of Drug Companies Safura Nantogmah.
Agents for Change in partnership with What junior doctors need to know about interactions with industry, transparency, and competing interests Faculty.
Security of the Distributed Electronic Patient Record: A Case-Based Approach James G. Anderson, Ph.D. Purdue University.
Research Conflicts of Interest: Identifying and Minimizing COI from the Perspective of Faculty July 30, 2009 PonJola Coney, MD Senior Associate Dean for.
Psychology Workforce Development for Primary Care Cynthia D. Belar, PhD, ABPP Executive Director, APA Education Directorate Collaborative.
+ Conflict of Interest in Physician-Industry Relationships.
© 2011 Partners Harvard Medical International Strategic Plan for Teaching, Learning and Assessment Program Teaching, Learning, and Assessment Center Strategic.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
A Focus on CME and Grants Nancy Coddington, PhD Senior Director, Compliance Operations AstraZeneca Pharmaceuticals LP And Terry Hisey Deputy Managing Principal.
Disclosure of Financial Conflicts of Interest in Continuing Medical Education Michael D. Jibson, MD, PhD and Jennifer Seibert, MD University of Michigan.
Fight On Training on NIH Conflict of Interest Rule and Introduction to diSClose Dan Shapiro Director, Research Compliance Ben Bell Manager, Research Compliance.
+ Role of Industry in Clinical Care, Research, and Education.
Partners Conflict of Interest Policy and Reporting October 11, 2012.
1 Harvard University Cambridge, MA March 29, 2007 Medical Device Congress AdvaMed’s Efforts to Promote Compliance Christopher L. White, Esq. Executive.
Copyright © Harvard Medical School. All Rights Reserved. Outside Activity Report: What Do I Need to Report?
Sara Lovell, CPCS Education Coordinator Providence Alaska Medical Center.
MEDICAL STUDENT TRANSITION COURSE Professionalism in the Clinical Environment ANTHONY A. MEYER, MD, PHD CHAIRMAN, DEPARTMENT OF SURGERY UNIVERSITY OF NORTH.
Shelly Rose Ziegler. Overview Gifts from Industry Industry Site Access Academic Activities Questions  Growing external perception that industry has influence.
Professional Responsibility Learning about Professional and Ethical Expectations.
Compliance Issues in Dealing With Drug and Device Manufacturers Presentation to The Sixth Annual National Congress On Health Care Compliance Paul E. Kalb,
The Importance of Internal Controls.  Why? The Importance of an Employee Handbook.
1 Survey of International Medical Graduates 2007.
Strategic Communications Training Crisis Communications X State MDA 1.
Pharmaceutical industry interactions in family medicine residencies have decreased since 2008 Steven R. Brown, MD, David V. Evans, MD, Adriane Fugh-Berman,
Disclosure of Financial Interest Policy. Medical Staff Policy Approved by the MEC’s Aimed at protecting the integrity of the LMHS Medical Staffs Requires.
PUBLICATION PRINCIPLES for PUBLICATION PROFESSIONALS
Clinical Learning Environment Review GMEC January 8, 2013
Disclosure UK Talking about Transparency.
Disclosure UK Talking about Transparency.
University of Pittsburgh
Lilly Grant Funding Disclosure May 27, 2008
An Introduction to the Sunshine Act
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Conflict of interest disclosure
Attitude Ethics and Communication AETCOM. Graduate Medical Regulations “Indian Medical Graduate” (IMG) possessing requisite knowledge, skills, attitudes,
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Presentation transcript:

Conflict of Interest Curriculum Eric Jackson, PharmD University of Connecticut School of Medicine Department of Family Medicine

Disclosure I currently have no relationships of any kind with any company whose products or services in any way relate to the practice of medicine, medical education or research.

Importance of Topic Our Institution’s COI Policy applies to both GME and UME Our Institution’s COI Policy applies to both GME and UME Implementation of the ACA and need for faculty to comply with Open Payments (Physician Payments Sunshine Act) Implementation of the ACA and need for faculty to comply with Open Payments (Physician Payments Sunshine Act) Need to address the so-called “Hidden Curriculum” Need to address the so-called “Hidden Curriculum”

Topics to Cover Resources for crafting & implementing strong COI policies & curricula at medical schools & academic medical centers Resources for crafting & implementing strong COI policies & curricula at medical schools & academic medical centers Open Payments Program (PPSA) Open Payments Program (PPSA) University of Connecticut SOM University of Connecticut SOM Conflict of Interest Policy Conflict of Interest Policy Conflict of Interest Curriculum Conflict of Interest Curriculum AMSA PharmFree (Just Medicine) Initiative AMSA PharmFree (Just Medicine) Initiative “Hidden” Curriculum “Hidden” Curriculum

RESOURCES Crafting and Implementing Strong COI Policies

The Prescription Project Advancing Medical Practice and Policy Launched by the Pew Charitable Trusts in Launched by the Pew Charitable Trusts in Led by Community Catalyst in partnership with the Institute on Medicine as a Profession. Led by Community Catalyst in partnership with the Institute on Medicine as a Profession. Promotes policy change among: Promotes policy change among: Academic Medical Centers Academic Medical Centers Professional Medical Societies Professional Medical Societies Public and Private payers Public and Private payers Seeks to Seeks to Eliminate COI created by industry marketing and Eliminate COI created by industry marketing and Expand the use of evidence-based medicine Expand the use of evidence-based medicine

Policy Guide for Academic Medical Centers and Medical Schools * Conflict of Interest Toolkit Competencies Competencies Accept the fact that marketing by pharmaceutical and medical device manufacturers is designed to influence physician behavior Accept the fact that marketing by pharmaceutical and medical device manufacturers is designed to influence physician behavior Recognize when marketing is occurring, even in the guise of education Recognize when marketing is occurring, even in the guise of education Acknowledge one’s own COI when unavoidable Acknowledge one’s own COI when unavoidable Effective Teaching Methods Effective Teaching Methods Teaching Opportunities Teaching Opportunities * March 2013/Conflict-of-Interest Curricula/Community Catalyst

COI Curriculum Toolkit - continued The general competencies can be taught in specific domains including practices related to: The general competencies can be taught in specific domains including practices related to: Small gifts Small gifts Pharmaceutical samples Pharmaceutical samples CME CME Speakers bureaus Speakers bureaus Ghostwriting and ‘honorary’ authorship Ghostwriting and ‘honorary’ authorship Purchasing/vendor relationships Purchasing/vendor relationships Consulting & research contracts with pharmaceutical & medical device companies Consulting & research contracts with pharmaceutical & medical device companies

Attitudes About Gifts “That stuff doesn’t influence me at all. I don’t even remember the name of the drug on my pen.” 85% of medical students in one study believed it improper for politicians to accept a gift. 85% of medical students in one study believed it improper for politicians to accept a gift. Only 46% thought it improper for them to accept gifts of similar value from a drug company. Only 46% thought it improper for them to accept gifts of similar value from a drug company. Palmisano P et al. J Med Edu 1980;55:453-5.

US Pharmaceutical Facts Source: The “research-based” drug industry spent > $15.5 billion on promotion - more than it spent on R&D The “research-based” drug industry spent > $15.5 billion on promotion - more than it spent on R&D 22% employed in R&D vs. 39% in marketing 22% employed in R&D vs. 39% in marketing 60 million “details” made by 83,000 drug reps 60 million “details” made by 83,000 drug reps 1,300 reps added by Astra-Zeneca for Nexium 1,300 reps added by Astra-Zeneca for Nexium > $10,000 per year is spent by the pharmaceutical industry on each US physician. > $10,000 per year is spent by the pharmaceutical industry on each US physician. Nearly one PR for every 11 practicing MDs. Nearly one PR for every 11 practicing MDs.

How Does Pharma Market Its Drugs & How Much Does it Spend?

CME vs. Pharmaceutical Marketing “Medical education is a powerful tool that can deliver your message to key audiences and get those audiences to take action that benefits your product.” “Medical education is a powerful tool that can deliver your message to key audiences and get those audiences to take action that benefits your product.” Spokesman for a Medical Education and Communication Company (MECC)

COI Curriculum Toolkit - continued Effective Teaching Methods Effective Teaching Methods Lecturing - least effective/most often used (84%) Lecturing - least effective/most often used (84%) Small group discussions using case-based examples more likely to be effective. Small group discussions using case-based examples more likely to be effective. Teaching Opportunities Teaching Opportunities Early on emphasizes importance by the faculty Early on emphasizes importance by the faculty Orientation Orientation Courses on Ethics and “Doctoring’ Courses on Ethics and “Doctoring’ Just before students begin their 3 rd year clerkships Just before students begin their 3 rd year clerkships In 4 th year after students finish residency interviews but before match results are known In 4 th year after students finish residency interviews but before match results are known Residency Training Residency Training “No Free Lunch” & supervised encounters with MSR’s “No Free Lunch” & supervised encounters with MSR’s

Open Payments Open Payments website: go.cms.gov/openpayments Will create greater transparency around the financial relationships of manufacturers, physicians, and teaching hospitals Will create greater transparency around the financial relationships of manufacturers, physicians, and teaching hospitals Makes no assumptions nor draws conclusions about information being collected & reported by industry Makes no assumptions nor draws conclusions about information being collected & reported by industry Provides an opportunity for providers & institutions to check the accuracy of info reported about them Provides an opportunity for providers & institutions to check the accuracy of info reported about them Access to preliminary data begins in August 2014 Access to preliminary data begins in August 2014 Release dates: Release dates: Aggregate data - September 30, 2014 Aggregate data - September 30, 2014 Detailed data on individuals - January 31, 2015 Detailed data on individuals - January 31, 2015

UConn SOM Conflict of Interest Policy* Purpose: to define parameters of appropriate interactions between students & faculty with industry representatives. Purpose: to define parameters of appropriate interactions between students & faculty with industry representatives. Liaison Committee on Medical Education requires affiliation agreements with voluntary physicians. Liaison Committee on Medical Education requires affiliation agreements with voluntary physicians. Adherence to this policy is expected in all educational settings. Adherence to this policy is expected in all educational settings. * Included in Academic Policies and Procedures Manual – Updated 7/3/13

COI Policy Statement Any interaction between members involved with the undergraduate medical education program and industry representatives which are or could be perceived as COI’s must be disclosed and appropriately managed

Scope of Policy Gifts & Meals Gifts & Meals Consulting Relationships Consulting Relationships Industry Sponsored Speakers Industry Sponsored Speakers Disclosure Disclosure Pharmaceutical Samples Pharmaceutical Samples Purchasing & Formularies Purchasing & Formularies Industry Sales Reps Attendance at Industry- Sponsored Lectures & Meetings Industry Support for Scholarships Funds for Trainees Disclosure requirement in SOM Curriculum

UConn SOM Conflict Of Interest Curriculum COI covered in COI covered in Orientation Orientation Human Development & Health Human Development & Health PCM 1 PCM 1 Student Professional Competency * Student Professional Competency * Ability to identify potential COI’s arising from Ability to identify potential COI’s arising from The influence of marketing & advertising The influence of marketing & advertising Financial & organizational arrangements Financial & organizational arrangements *Included under ‘Integrity’ in the Code of Professionalism for Medical Students

Orientation Planned for next year One hour session using team-based learning to assess initial understanding, provide some learning materials, have students work as a team through a typical case that they may encounter as a first year student, and then to end with a post-test. One hour session using team-based learning to assess initial understanding, provide some learning materials, have students work as a team through a typical case that they may encounter as a first year student, and then to end with a post-test. Goal: provide a brief introduction to COI issues before students begin SCP. Goal: provide a brief introduction to COI issues before students begin SCP.

Human Development & Health Year 1: Health Law & Ethics First session (2 hours): First session (2 hours): Introduction & Overview of HLE Introduction & Overview of HLE Doctors, Patients & Society Doctors, Patients & Society One Goal: One Goal: Recognize legal & ethical issues as part of dynamic relationships between doctor-patient and doctor-society Recognize legal & ethical issues as part of dynamic relationships between doctor-patient and doctor-society Assigned Reading for first session Assigned Reading for first session ACP Ethics Manual: Ann Intern Med 2012;156: ACP Ethics Manual: Ann Intern Med 2012;156:

ACP Ethics Manual, 6 th Edition Physician-Industry Relations & Gifts Determining Appropriateness What is the purpose of the industry offer? What is the purpose of the industry offer? What would my patients or the public think about this arrangement? What would my patients or the public think about this arrangement? What would my colleagues think about this arrangement? What would my colleagues think about this arrangement? What would I think if my own physician accepted this offer? What would I think if my own physician accepted this offer? How would I feel if the relationship was disclosed through the media? “Sunshine Test” How would I feel if the relationship was disclosed through the media? “Sunshine Test”

Human Development & Health Year 2: Pharmaceutical Law & Policy Part 1: Regulation of drug development, intellectual property & costs of pharmaceuticals Part 1: Regulation of drug development, intellectual property & costs of pharmaceuticals Deals with intellectual property and drug approval processes Deals with intellectual property and drug approval processes Drug licensing & approval process aims to insure safety & efficacy while protecting the interests (patents) of developers. Drug licensing & approval process aims to insure safety & efficacy while protecting the interests (patents) of developers. Part 2: Industry-provider Relationships & COI’s Part 2: Industry-provider Relationships & COI’s Health industry behaviors that create COI’s Health industry behaviors that create COI’s Understand the effects of industry marketing on physician education & practice and Understand the effects of industry marketing on physician education & practice and Marketing’s relationship to medical professionalism Marketing’s relationship to medical professionalism * Both parts are required for top score on Curriculum in AMSA Scorecard

PCM 1 Group discussion using scenarios to get students thinking about the complexities of clinician- pharmaceutical industry interactions. Group discussion using scenarios to get students thinking about the complexities of clinician- pharmaceutical industry interactions. Most students interact with Pharm reps from the moment they start having clinical encounters & have seen the gifts (big & small) reps leave at clinical sites. Most students interact with Pharm reps from the moment they start having clinical encounters & have seen the gifts (big & small) reps leave at clinical sites. One scenario has a student reporting to his SCP on a Tuesday afternoon just in time for lunch provided by a rep detailing his new BP lowering med “Tekturna”

Pharm Rep Lunch Scenario Should the student Should the student Politely decline lunch & listen to the talk? Politely decline lunch & listen to the talk? Enjoy the food & listen to the talk? Enjoy the food & listen to the talk? Subsequent discussion with preceptor about Subsequent discussion with preceptor about Validity of info provided about the medication Validity of info provided about the medication Relevance of info to a specific patient encountered Relevance of info to a specific patient encountered Pros & Cons of using samples Pros & Cons of using samples

Revitalizing Professionalism AMSA’s PharmFree Initiative

Revitalizing Professionalism AMSA’s “Just Medicine” Initiative

AMSA Just Medicine Campaign Established in 2002 to advocate for Evidence-based rather than marketing-based prescribing practice Evidence-based rather than marketing-based prescribing practice Global access to essential medicines Global access to essential medicines Removal of conflicts of interest in medicine Removal of conflicts of interest in medicine Name changed to “Just Medicine” as it addresses much more than COIs. Name changed to “Just Medicine” as it addresses much more than COIs.

Just Medicine Scorecard (AMSA & The Pew Charitable Trusts) First released in 2007, revised in 2008 First released in 2007, revised in 2008 Letter grade assigned to COI Policies at AMC’s Letter grade assigned to COI Policies at AMC’s Based on implementation of recommendations in the AAMC Report on Industry Funding of Medical Education to mitigate/eliminate COI’s. Based on implementation of recommendations in the AAMC Report on Industry Funding of Medical Education to mitigate/eliminate COI’s. Schools adopting ‘strong’ policies (A or B) Schools adopting ‘strong’ policies (A or B) 30% in % in % in 2013 !! 72% in 2013 !! We received a ‘B’ on the 2013 Scorecard We received a ‘B’ on the 2013 Scorecard

AMSA Scorecard 2013 UConn SOM Commentary Policy significantly improved & is fairly strong overall Policy significantly improved & is fairly strong overall Model domains: Model domains: Gifts & Meals Gifts & Meals Purchasing & Formularies Purchasing & Formularies Industry Support for Scholarships/Funds for trainees Industry Support for Scholarships/Funds for trainees Medical School Curriculum* Medical School Curriculum* Policies specify an oversight mechanism Policies specify an oversight mechanism

AMSA Scorecard 2013 UConn SOM Commentary Recommendations for improvement: Recommendations for improvement: Address consulting relationships Address consulting relationships Policy seems mainly aimed at trainee interactions with industry Policy seems mainly aimed at trainee interactions with industry Does not address consulting relationships Does not address consulting relationships Address explicit policies regarding off-site education supported by industry. Address explicit policies regarding off-site education supported by industry. Rather than asking trainees to pay attention to who funds the offsite event, Rather than asking trainees to pay attention to who funds the offsite event, Just prohibit attendance at all industry-supported events Just prohibit attendance at all industry-supported events

Scorecard Grade Looks Good But What About the “Hidden Curriculum”? During the clinical years of medical school, students often see concerning interactions, opinions, & expectations when it comes to attending/resident/student interactions & relationships with industry. During the clinical years of medical school, students often see concerning interactions, opinions, & expectations when it comes to attending/resident/student interactions & relationships with industry. The AMSA Scorecard project was born from these concerns when a few med students thought, ‘I wonder if medical schools have specific COI policies”. The AMSA Scorecard project was born from these concerns when a few med students thought, ‘I wonder if medical schools have specific COI policies”.

Hidden Curriculum Trainees tend to do as we do, not as we say. Trainees tend to do as we do, not as we say. Actions speak louder than words Actions speak louder than words COI Curriculum should be reflected in all of our academic & clinical activities COI Curriculum should be reflected in all of our academic & clinical activities

Just Medicine Fellow Comment on the Scorecard “My hope is that pre-med applicants look at the Scorecard to gauge the values and interests of the medical schools they apply to.”

In Conclusion Our Institutional COI Policy is strong Our Institutional COI Policy is strong The Medical School COI Curriculum is ‘fairly strong’ and is improving The Medical School COI Curriculum is ‘fairly strong’ and is improving AMSA’s Just Medicine Campaign & Scorecard came primarily from concerns about experiences during clinical rotations. AMSA’s Just Medicine Campaign & Scorecard came primarily from concerns about experiences during clinical rotations. Questions or Comments?